Search results
Novavax seeks FDA approval for updated Covid-19 vaccine
Pharmaceutical Technology via Yahoo Finance· 2 days ago"Novavax seeks FDA approval for updated Covid-19 vaccine" was originally created and published by...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 5 hours agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 5 days agoThis is appealing to people who are uneasy with the newer mRNA technology. But the competitor...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 4 days agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
Novavax applies for FDA nod for its updated COVID vaccine
Center for Infectious Disease Research and Policy· 23 hours agoThe company said it will have the vaccine ready to distribute in mid July as prefilled syringes, pending approval and recommendations.
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 4 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 6 days agoEarlier in the year, one analyst called results from the cancer vaccine study "transformational."...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 4 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 5 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 6 days agoA new round of Covid shots will likely reach Americans in the coming months. Here's what we know...